This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pankaj R Patel, Chairman, Zydus Lifescience, has been conferred with the Padma Bhushan by the Government of India. With a Masters in Pharmaceutics and Pharmaceutical Technology from the L.M. College of Pharmacy and alumni of the Indian Institute of Management (IIM), Ahmedabad, he was always driven by a passion to become a pharma entrepreneur. Patel combines both research and techno-commercial expertise.
The Battle for Generic Medications: A Recent Patent Dispute As we continue to navigate the complex world of pharmaceuticals, it's essential to stay informed about the latest developments in patent disputes. Recently, Astellas Pharma Inc. found itself in a high-stakes battle with Creekwood Pharmaceuticals LLC over the rights to a generic version of their medication.
The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) announces its renewed commitment to strengthening the strategic partnership between India and the United Arab Emirates (UAE) in the pharmaceutical sector. On January 23, 2025, Raja Bhanu, Director General of PHARMEXCIL along with the AVPS Chakravarthi, Honorary Advisor, Pharmexcil, met Aref Ali Alnuaimi, Consul General, UAE, in Hyderabad.
Current rules leave door open for medicines to be supplied without appropriate patient consultation, association says Pharmacies are demanding tougher regulation of the online sale of weight-loss jabs amid a predicted new years boom in demand. The National Pharmacy Association (NPA), who represent independent community pharmacies, urged the regulator to require greater consultation with patients before dispensing weight-loss jabs and other high-risk medication online.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Battle for Sleep: A Patent Dispute that Could Shake the CNS Market As we navigate the complexities of the pharmaceutical industry, it's not uncommon to come across disputes over patents and intellectual property. But the recent case of Avadel CNS Pharmaceuticals LLC v. Jazz Pharmaceuticals Inc. is one that's caught our attention. At the heart of this dispute is the patent for Xyrem, a medication used to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy.
In this episode, I’ll discuss when dialysis is recommended to be used to treat ethylene glycol poisoning. Episode 995: Expert Recommendations For Using Dialysis to Treat Ethylene Glycol Poisoning Subscribe on iTunes , Android , or Stitcher The metabolites of ethylene glycol (glycolate and oxalate) are responsible for the development of metabolic acidosis, neurotoxicity, acute kidney injury, and mortality.
In this episode, I’ll discuss when dialysis is recommended to be used to treat ethylene glycol poisoning. Episode 995: Expert Recommendations For Using Dialysis to Treat Ethylene Glycol Poisoning Subscribe on iTunes , Android , or Stitcher The metabolites of ethylene glycol (glycolate and oxalate) are responsible for the development of metabolic acidosis, neurotoxicity, acute kidney injury, and mortality.
Organizations that focus on improving patient outcomes and reducing healthcare costs rely on real-world data to guide and support their mission. Being able to extract meaningful insights from this data is vital.
The Battle for Generic Medication Access: A Case Study in Patent Disputes As we navigate the complex world of pharmaceuticals, it's essential to understand the intricate dance between patent holders and generic manufacturers. A recent court case, Nexus Pharmaceuticals LLC v. Hikma Pharmaceuticals USA Inc., highlights the challenges and opportunities that arise when these two worlds collide.
Type II diabetes is a complicated disease state that often requires a combination of medications to control. However, some combinations of antidiabetes medications, such as sulfonylureas and basal insulin, may lead to unintended adverse effects. In this article, we explore the risks, benefits, and clinical considerations of combining sulfonylureas with long-acting insulin.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The Battle for Generic Medications: A Look at Pfizer Inc. v. Alkem Laboratories Limited As we navigate the complex world of pharmaceuticals, it's essential to understand the intricacies of patent law and its impact on the availability of generic medications. A recent case, Pfizer Inc. v. Alkem Laboratories Limited, has shed light on the challenges faced by generic manufacturers and the importance of patent protection.
An article that was written by U.S. Department of Health and Human Services employees and slated for publication in a medical journal this spring was placed on hold last week, apparently as a result of the Trump administration freeze on communications from government agencies. The article reviewed the responsibilities of institutions that receive federal funding for research and was to have appeared in the Journal of Law, Medicine & Ethics.
Patent Disputes in the Global Market: A Cautionary Tale As a business leader, you're likely no stranger to the world of intellectual property and patent disputes. But have you ever stopped to think about the real-world implications of these disputes on your company's bottom line? Take the case of Taizhou Luqiao Shengqiang Housewares Factory v. DBest Products Inc.
52
52
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
102 
Let's personalize your content